Pharmaceutical intermediates
Ixazomib Citrate Intermediates
2 pharmaceutical intermediates for Ixazomib Citrate. Indication: Multiple Myeloma.
About Ixazomib Citrate
- Originator
- Millennium Pharmaceuticals Inc
- Indication
- Multiple Myeloma
Available intermediates
2 intermediates currently listed for Ixazomib Citrate. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate | 179324-87-9 | / | / |
| CHEMBRDG-BB 7959525 | 667403-46-5 | / | / |
Building toward Ixazomib Citrate?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →